Lifecore Biomedical, Inc. (LFCR) Q3 2024 Earnings Call

Investor webinar replay

Replay transcript excerpt

we'll be in a listen-only mode. Now, I would like to turn the call over to Stephanie Diaz, Manager of Investor Relations for LifeCorps. Good afternoon, and thank you for joining us today to discuss LifeCorps Biomedical's third quarter fiscal 2025 earnings results. Hosting the call today from LifeCorps are Paul Josephs, President and Chief Executive Officer, and Ryan Lake, Chief Financial Officer. Before we begin today, we'd like to remind everyone that certain statements made in the course of this conference call contain forward-looking statements. It is important to note that the forward-looking statements made during this call reflect management's judgment and analysis only as of today, April 3rd, 2025, and the company's actual results could differ materially from those projected in such forward-looking statements. For a more thorough discussion of the risks and uncertainties associated with any forward-looking statements, please see the disclaimer regarding forward-looking statements that is included in our fiscal 2025 third quarter earnings release, which was furnished to the SEC today on Form 8K, as well as our other filings with the Securities and Exchange Commission, including but not limited to the company's Form 10Q for the third quarter of fiscal 2025, which was filed this afternoon. With that, I'd like to turn the call over to Paul Josephs, Chief Executive Officer. Thank you, Stephanie. Good afternoon, everyone, and thank you for joining us for our fiscal 2025 third quarter update. During the third quarter, LifeCorps continued to aggressively and successfully execute against our stated plan for the year, with noteworthy accomplishments across multiple areas of our business. During the period, our team signed multiple new agreements with both new and existi...